Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure

  • Mora-Ayestarán, Nerea|||0000-0002-2127-5287
  • Ochoa, Juan Pablo|||0000-0002-7966-0313
  • Gómez-González, Cristina
  • Navarro-Peñalver, Marina
  • Gallego-Delgado, María|||0000-0003-0726-9646
  • Larrañaga-Moreira, José M.|||0000-0002-8370-5158
  • Robles-Mezcua, Ainhoa
  • Basurte-Elorz, María Teresa|||0000-0002-8689-0301
  • Rodriguez-Palomares, Jose Fernando
  • Climent-Paya, Vicente
  • Jiménez-Jaímez, Juan
  • Mogollón-Jiménez, Maria Victoria
  • García-Granja, Pablo Elpidio|||0000-0002-0750-1567
  • García-Álvarez, Ana|||0000-0002-1718-2424
  • Peña-Peña, María Luisa
  • Alvarez Barredo, María|||0000-0002-8545-8138
  • Ripoll-Vera, Tomás|||0000-0001-9222-325X
  • Palomino-Doza, Julián
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Tirón, Coloma
  • Fernández, Ana Isabel|||0000-0002-1509-5191
  • Sabater-Molina, María
  • Toranzo, Inés
  • Crespo-Leiro, Maria Generosa|||0000-0002-3085-167X
  • Doncel-Abad, Victoria
  • Lacuey-Lecumberri, Gemma
  • Limeres-Freire, Javier
  • García-Álvarez, Maria I
  • Cabrera-Borrego, Eva|||0000-0003-2997-2391
  • Kounka-Ait El Maalem, Zineb
  • Vilches, Silvia
  • González-López, Esther
  • Villacorta, Eduardo|||0000-0003-0486-1740
  • García Pinilla, José Manuel|||0000-0001-5999-5741
  • Barriales-Villa, Roberto|||0000-0002-6721-3487
  • Gimeno-Blanes, Juan Ramón
  • García-Pavía, Pablo|||0000-0002-5470-2257
  • Domınguez, Fernando|||0000-0001-8408-363X
Certain genetic forms of dilated cardiomyopathy (DCM) entail a higher arrhythmic risk. It is unknown whether DCM patients with high-risk arrhythmic genotypes also develop more advanced heart failure (AHF) complications. AHF events were studied according to DCM genotype. Clinical data from 1203 genotyped DCM patients were collected from 19 Spanish centres. Patients were classified into high-risk arrhythmic genotypes (LMNA, FLNC, desmosomal genes, PLN, TMEM43, RBM20), TTN, other genes, and genotype negative (Gen-). The primary endpoint was a composite of AHF events (ventricular assist device implantation, heart transplant, and AHF-related mortality). The secondary endpoint was a combination of malignant ventricular arrhythmias (MVA). A DCM-causing variant was identified in a high-risk arrhythmic gene in 185 patients (15.4%), 193 (16.0%) had variants in TTN, 134 (11.1%) in other genes, and 691 (57.4%) were Gen-. After a median follow-up of 5.7 years (interquartile range 2.9-9.1 years), AHF events occurred in 45 (24.3%) patients in the high-risk arrhythmic group, while in 25 (18.7%), 25 (13.0%), and 70 (10.1%) patients with other genotypes, TTN, and Gen-, respectively (hazard ratio 1.85, 95% confidence interval 1.31-2.61 for high-risk arrhythmic genes compared with other groups). MVA occurred in 55 patients (29.7%) (hazard ratio 2.52, 95% confidence interval 1.81-3.51 for high-risk genotypes vs other groups). High-risk arrhythmic genotype was the main independent predictor of AHF in multivariate analysis. High-risk arrhythmic genotype and late gadolinium enhancement were independent predictors of MVA. Patients with high-risk arrhythmic genotypes also experience more AHF events, supporting a differential therapeutic approach in this group of patients beyond sudden death prevention.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy

  • Escobar-Lopez, Luis|||0000-0002-4354-7263
  • Ochoa, Juan Pablo|||0000-0002-7966-0313
  • Royuela, Ana
  • Verdonschot, Job A.J.
  • Ferro, Matteo Dal
  • Espinosa, Maria Angeles
  • Sabater-Molina, Maria
  • Gallego-Delgado, María|||0000-0003-0726-9646
  • Larrañaga-Moreira, Jose M.
  • García Pinilla, José Manuel|||0000-0001-5999-5741
  • Basurte-Elorz, María Teresa|||0000-0002-8689-0301
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Climent, Vicente|||0000-0001-7362-1922
  • Bermudez Jimenez, Francisco J.|||0000-0003-0325-7349
  • Mogollón-Jiménez, María Victoria
  • Lopez, Javier
  • Peña-Peña, Maria Luisa
  • García-Álvarez, Ana|||0000-0002-1718-2424
  • López-Abel, Bernardo
  • Ripoll-Vera, Tomás|||0000-0001-9222-325X
  • Palomino-Doza, Julian
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Brugada, Ramon|||0000-0001-6607-3032
  • Idiazabal, Uxua
  • Mirelis, Jesus G.
  • Dominguez, Fernando
  • Henkens, Michiel T.H.M.
  • Krapels, Ingrid P.C.
  • Brunner, Han G.
  • Paldino, Alessia
  • Zaffalon, Denise
  • Mestroni, Luisa
  • Sinagra, Gianfranco|||0000-0003-2700-8478
  • Heymans, Stephane R.B.
  • Merlo, Marco|||0000-0002-1022-3131
  • García-Pavia, Pablo
Although genotyping allows family screening and influences risk-stratification in patients with nonischemic dilated cardiomyopathy (DCM) or isolated left ventricular systolic dysfunction (LVSD), its result is negative in a significant number of patients, limiting its widespread adoption. This study sought to develop and externally validate a score that predicts the probability for a positive genetic test result (G+) in DCM/LVSD. Clinical, electrocardiogram, and echocardiographic variables were collected in 1,015 genotyped patients from Spain with DCM/LVSD. Multivariable logistic regression analysis was used to identify variables independently predicting G+, which were summed to create the Madrid Genotype Score. The external validation sample comprised 1,097 genotyped patients from the Maastricht and Trieste registries. A G+ result was found in 377 (37%) and 289 (26%) patients from the derivation and validation cohorts, respectively. Independent predictors of a G+ result in the derivation cohort were: family history of DCM (OR: 2.29; 95% CI: 1.73-3.04; P < 0.001), low electrocardiogram voltage in peripheral leads (OR: 3.61; 95% CI: 2.38-5.49; P < 0.001), skeletal myopathy (OR: 3.42; 95% CI: 1.60-7.31; P = 0.001), absence of hypertension (OR: 2.28; 95% CI: 1.67-3.13; P < 0.001), and absence of left bundle branch block (OR: 3.58; 95% CI: 2.57-5.01; P < 0.001). A score containing these factors predicted a G+ result, ranging from 3% when all predictors were absent to 79% when ≥4 predictors were present. Internal validation provided a C-statistic of 0.74 (95% CI: 0.71-0.77) and a calibration slope of 0.94 (95% CI: 0.80-1.10). The C-statistic in the external validation cohort was 0.74 (95% CI: 0.71-0.78). The Madrid Genotype Score is an accurate tool to predict a G+ result in DCM/LVSD. (J Am Coll Cardiol 2022;80:1115-1126) © 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy, genotype-phenotype correlation

  • De Frutos, Fernando|||0000-0003-4350-3217
  • Ochoa, Juan Pablo|||0000-0002-7966-0313
  • Fernández, Ana Isabel|||0000-0002-1509-5191
  • Gallego-Delgado, María|||0000-0003-0726-9646
  • Navarro-Peñalver, Marina
  • Casas, Guillem|||0000-0001-7122-320X
  • Basurte-Elorz, María Teresa|||0000-0002-8689-0301
  • Larrañaga-Moreira, José María
  • Mogollón, María Victoria
  • Robles-Mezcua, Ainhoa
  • García-Granja, Pablo Elpidio|||0000-0002-0750-1567
  • Climent, Vicente|||0000-0001-7362-1922
  • Palomino-Doza, Julián
  • García-Álvarez, Ana|||0000-0002-1718-2424
  • Brion, María|||0000-0001-7463-2148
  • Brugada, Ramon|||0000-0001-6607-3032
  • Jiménez-Jáimez, Juan|||0000-0001-5541-898X
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Ripoll-Vera, Tomás|||0000-0001-9222-325X
  • Peña-Peña, María Luisa
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Gonzalez-Carrillo, Josefa
  • Villacorta, Eduardo|||0000-0003-0486-1740
  • Espinosa, Maria Angeles
  • García-Pavía, Pablo|||0000-0002-5470-2257
  • Mirelis, Jesus G.
Late gadolinium enhancement (LGE) is frequently found in patients with dilated cardiomyopathy (DCM); there is little information about its frequency and distribution pattern according to the underlying genetic substrate. We sought to describe LGE patterns according to genotypes and to analyse the risk of major ventricular arrhythmias (MVA) according to patterns. Cardiac magnetic resonance findings and LGE distribution according to genetics were performed in a cohort of 600 DCM patients followed at 20 Spanish centres. After exclusion of individuals with multiple causative gene variants or with variants in infrequent DCM-causing genes, 577 patients (34% females, mean age 53.5 years, left ventricular ejection fraction 36.9 ± 13.9%) conformed to the final cohort. A causative genetic variant was identified in 219 (38%) patients, and 147 (25.5%) had LGE. Significant differences were found comparing LGE patterns between genes (P < 0.001). LGE was absent or rare in patients with variants in TNNT2, RBM20, and MYH7 (0, 5, and 20%, respectively). Patients with variants in DMD, DSP, and FLNC showed a predominance of LGE subepicardial patterns (50, 41, and 18%, respectively), whereas patients with variants in TTN, BAG3, LMNA, and MYBPC3 showed unspecific LGE patterns. The genetic yield differed according to LGE patterns. Patients with subepicardial, lineal midwall, transmural, and right ventricular insertion points or with combinations of LGE patterns showed an increased risk of MVA compared with patients without LGE. LGE patterns in DCM have a specific distribution according to the affected gene. Certain LGE patterns are associated with an increased risk of MVA and with an increased yield of genetic testing.